Oral-contraceptive use and risk of hip fracture: A case-control study

Lancet

Volumn 353, Issue 9163, 1999, Pages 1481-1484

  Michaëlsson, Karl ^a   Baron, John A ^b   Farahmand, Bahman Y ^c   Persson, Ingemar ^d   Ljunghall, Sverker ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c STOCKHOLM COUNTY COUNCIL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HIP FRACTURE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SWEDEN; TELEPHONE;

EID: 0033135999     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)09044-8     Document Type: Article

References (34)

1. Christiansen C, Lindsay R. Estrogens, bone loss and preservation. Osteoporos Int 1990; 1: 7-13.
2. Rizzoli R, Bonjour J-P. Hormones and bones. Lancet 1997; 349 (suppl I): sI20-26.
3. Michaëlsson K, Baron JA, Farahmand BY, et al. Hormone replacement therapy and hip fracture risk: population based case-control study. BMJ 1998; 316: 1858-63.
4. Corson SL. Oral contraceptives for the prevention of osteoporosis. J Reprod Med 1993; 38: 1015-20.
5. DeCherney A. Bone-sparing properties of oral contraceptives. Am J Obstet Gynecol 1996; 174: 15-20.
6. Naessén T, Parker R, Persson I, Zack M, Adami H-O. Time trends in incidence rates of first hip fracture in the Uppsala health care region, Sweden, 1965-1983. Am J Epidemiol 1989; 130: 289-99.
7. Magnusson C, Baron JA, Persson I, et al. Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer 1998; 76: 29-34.
8. Recker RR, Davies KM, Hinders SM, Heaney RP, Stegman MR, Kimmel DB. Bone gain in young adult women. JAMA. 1992; 268: 2403-08.
9. Stevenson JC, Lees B, Devenport M, Cust MP, Ganger KF. Determinants of bone density in normal women: risk factors for future osteoporosis? BMJ 1989; 298: 924-28.
10. Tuppurrainen M, Kröger H, Saarikoski S, Honkanen R, Alhava E. The effect of previous oral contraceptive use on bone mineral density in perimenopausal women. Osteoporosis Int 1994; 4: 93-98.
11. Gambacciani M, Spinetti A, Taponeco F, Cappagli B, Piaggesi L, Fioretti P. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Obstet Gynecol 1994; 83: 392-96.
12. Enzelberger H, Metka M, Heytmanek G, Schurz B, Kurz C, Kusztrich M. Influence of oral contraceptive use on bone density in climacteric women. Maturitas 1988; 9: 375-78.
13. Hansen MA, Overgaard K, Riis BJ, Christiansen C. Potential risk factors for development of postmenopausal osteoporosis - examined over 12-year period. Osteoporos Int 1991; 1: 95-102.
14. Kleerekoper M, Brienza RS, Schultz LR, Cole Johnson C. Oral contraceptive use may protect against low bone mass. Arch Intern Med 1991; 151: 1971-76.
15. Fortney JA, Feldblum PJ, Talmage RV, Zhang J, Godwin SE. Bone mineral density an history of oral contraceptive use. J Reprod Med 1994; 39: 105-09.
16. Goldsmith NF, Johnston JO. Bone mineral effects of oral contraceptives, pregnancy and lactation. J Bone Joint Surg Am 1975; 57: 657-68.
17. Lindsay R, Tohme J, Kanders B. The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women. Contraception 1986; 34: 333-40.
18. Mazess RB, Barden S. Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth-control pills. Am J Clin Nutr 1991; 53: 132-42.
19. Hreschyshyn MM, Hopkins Z, Zylstra S, Anbar M. Associations of pariety, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities. Am J Obstet Gynecol 1998; 159: 318-22.
20. O'Neill TW, Silman AJ, Naves Diaz M, Cooper C, Kanis J, Felsenberg D. Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. Osteoporos Int 1997; 7: 72-78.
21. Mallmin H, Ljunghall S, Persson I, Bergstrom R. Risk factors for fractures of the distal forearm: a population-based case-control study. Osteoporos Int 1994; 4: 298-304.
22. Johansson C, Mellström D. An earlier fracture as a risk factor for new fracture and its association with smoking and menopausal age in women. Maturitas 1996; 24: 97-106.
23. O'Neill TW, Marsden D, Adams JE, Silman AJ. Risk factors, falls, and fracture of the distal forearm in Manchester, UK. J Epidemiol Community Health 1996; 50: 288-92.
24. Cooper C, Hannaford P, Croft P, Kay CR. Oral contraceptive pill use and fractures in women: a prospective study. Bone 1993; 14: 41-45.
25. Hillard TC, Stevenson JC. Role of oestrogen in the development of osteoporosis. Calcif Tissue Int 1991; 49: 55-59.
26. Goulding A, McChesney R. Oestrogen-progestogen oral contraceptives and urinary calcium excretion. Clin Endocrinol 1977; 6: 449-54.
27. Heaney RP. Calcium in the prevention and treatment of osteoporosis. J Intern Med 1992; 231: 169-80.
28. Prior JC. Progesterone as a bone-trophic hormone. Endocr Rev 1990; 11: 386-98.
29. Baran DT. Magnitude and determinants of premenopausal bone loss. Osteoporos Int 1994; 4: 31-34.
30. Steinberg KK, Freni-Titulaer LW, DePuey EG, et al. Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab 1987; 65: 697-702.
31. Nilas L, Christiansen C. Bone mass and its relationship to age an dthe menopause. J Clin Endocrinol Metab 1987; 65: 697-702.
32. Musey VC, Collins DC, Musey PI, Martino-Saltzman D, Preedy JRK. Age-related changes in the female hormonal environment during reproductive life. Am J Obstet Gynecol 1987; 157: 312-17.
33. Nischan P, Ebeling K, Thomas DB, Hirsch U. Comparison of recalled and validated oral contraceptive histories. Am J Epidemiol 1993; 138: 697-703.
34. Norell SE, Boethius G, Persson I. Oral contraceptive use: interview data versus pharmacy records. Int J Epidemiol 1998; 27: 1033-37.